Sign in
4

Changes in Ownership

Harmony Biosciences Holdings, Inc. Filed Acc 0001104659-22-002722

Chief Commercial Officer sold 6,125 shares at an average $40.37 ($247,258)

  • Chief Commercial Officer acquired 6,125 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Dierks Jeffrey · Chief Commercial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2022-01-06 Exercise or conversion : show line 1 in the form +6,125 $8.22 $50,348 6,125 D
2022-01-06 Sale : show line 2 in the form −1,399 $39.60 $55,396 4,726 D
2022-01-06 Sale : show line 3 in the form −4,302 $40.53 $174,379 424 D
2022-01-06 Sale : show line 4 in the form −424 $41.23 $17,482 0 D
Open-market sales · 6,125 sh · avg $40.37 · $247,258

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-01-06 Exercise or conversion : show line 5 in the form Stock Option −3,690 9,739 D
2022-01-06 Exercise or conversion : show line 6 in the form Stock Option −2,435 4,869 D
Loading xslF345X03/tm221863-2_4seq1.xml…